CA1109796A - Process for the production of novel antidiarrheal agents - Google Patents

Process for the production of novel antidiarrheal agents

Info

Publication number
CA1109796A
CA1109796A CA294,379A CA294379A CA1109796A CA 1109796 A CA1109796 A CA 1109796A CA 294379 A CA294379 A CA 294379A CA 1109796 A CA1109796 A CA 1109796A
Authority
CA
Canada
Prior art keywords
pharmaceutical preparation
active ingredient
encephaline
administration
content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA294,379A
Other languages
English (en)
French (fr)
Inventor
Roland Jaques
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy Investments Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Investments Ltd filed Critical Ciba Geigy Investments Ltd
Application granted granted Critical
Publication of CA1109796A publication Critical patent/CA1109796A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA294,379A 1977-01-07 1978-01-05 Process for the production of novel antidiarrheal agents Expired CA1109796A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU76538A LU76538A1 (no) 1977-01-07 1977-01-07
LU76538 1977-01-07

Publications (1)

Publication Number Publication Date
CA1109796A true CA1109796A (en) 1981-09-29

Family

ID=19728442

Family Applications (1)

Application Number Title Priority Date Filing Date
CA294,379A Expired CA1109796A (en) 1977-01-07 1978-01-05 Process for the production of novel antidiarrheal agents

Country Status (13)

Country Link
JP (1) JPS5388332A (no)
AU (1) AU3221778A (no)
BE (1) BE862689A (no)
CA (1) CA1109796A (no)
DE (1) DE2800110A1 (no)
FR (1) FR2376663A1 (no)
GB (1) GB1595021A (no)
IE (1) IE46241B1 (no)
IL (1) IL53760A (no)
IT (1) IT7847545A0 (no)
LU (1) LU76538A1 (no)
NL (1) NL7800045A (no)
ZA (1) ZA7887B (no)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783193A (en) * 1991-06-21 1998-07-21 The University Of Cincinnati Oral administration of therapeutic proteins for treatment of autoimmune disease, transplant rejection and infectious disease
US6613332B1 (en) 1991-06-21 2003-09-02 The University Of Cincinnati Oral administration of therapeutic proteins

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668517A (en) * 1985-04-04 1987-05-26 Norwich Eaton Pharmaceuticals, Inc. Furazolidone dosage form
NL8503413A (nl) * 1985-12-11 1987-07-01 Vereniging Voor Christelijk Wetenschappelijk Onderwijs Preparaten ter bestrijding van diarrhee.

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783193A (en) * 1991-06-21 1998-07-21 The University Of Cincinnati Oral administration of therapeutic proteins for treatment of autoimmune disease, transplant rejection and infectious disease
US6174529B1 (en) 1991-06-21 2001-01-16 University Of Cincinnati Oral therapy for the treatment of allergies and method of manufacture
US6613332B1 (en) 1991-06-21 2003-09-02 The University Of Cincinnati Oral administration of therapeutic proteins

Also Published As

Publication number Publication date
IL53760A0 (en) 1978-04-30
IT7847545A0 (it) 1978-01-06
IE46241B1 (en) 1983-04-06
IE780032L (en) 1978-07-07
LU76538A1 (no) 1978-09-18
GB1595021A (en) 1981-08-05
JPS5388332A (en) 1978-08-03
AU3221778A (en) 1979-07-12
FR2376663B1 (no) 1981-11-20
DE2800110A1 (de) 1978-07-13
FR2376663A1 (fr) 1978-08-04
BE862689A (fr) 1978-07-06
ZA7887B (en) 1978-11-29
NL7800045A (nl) 1978-07-11
IL53760A (en) 1981-07-31

Similar Documents

Publication Publication Date Title
US4309404A (en) Sustained release pharmaceutical compositions
US4309406A (en) Sustained release pharmaceutical compositions
EP0129382B1 (en) Long-acting formulation of cefaclor and its preparation
US4309405A (en) Sustained release pharmaceutical compositions
US7374781B2 (en) Sustained release formulations containing acetaminophen and tramadol
CA1147651A (en) Sustained release pharmaceutical compositions
EP0260236B1 (en) Composition comprising l-dopa
IE861139L (en) Timed disintergration capsules
JP3249970B2 (ja) ペプチドを経口投与するための安定化組成物
IE850744L (en) Storage-stable, quick-disintegrating pharmaceuticals
NZ220097A (en) Oral pharmaceutical preparations with acid-labile active ingredients
GB2056278A (en) Sustained release compositions
GB2204241A (en) Fat coated pharmaceutical compositions
EP0495270B1 (en) Azaribine composition
ZA200309048B (en) Pharmaceutical formulation for the efficient administration of apomorphine, 6aR-(-)-N-propyl-norapomorphine and their derivatives and pro-drugs thereof.
CZ369292A3 (en) Per-orally applicable form of a medicament for treating central states of dopamine insufficiency
CA1255598A (en) Pharmaceutical compositions with analgesic properties and the preparation and use thereof
EP0078079B1 (en) Nitrofurantoin dosage form
US5213806A (en) Pharmaceutical composition comprising calcium polycarbophil
CA2032475C (en) Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines
CA1109796A (en) Process for the production of novel antidiarrheal agents
US4180559A (en) Coated 1-(2-chlorodibenzo[b,f]oxepin-10-yl)-4-methylpiperazine compositions
US4411882A (en) Galenical compositions
US3485914A (en) Process for the production of a pharmaceutical antibiotic preparation having delayed therapeutic action and the composition prepared according to such process
US3140229A (en) Laxative compositions containing (4, 4'-dihydroxy-2''-amino)-triphenylmethane and method of using same

Legal Events

Date Code Title Description
MKEX Expiry